Plus   Neg

PharmaSGP Sets IPO Price Range - Quick Facts

PharmaSGP Holding SE has set the price range for its planned initial public offering at 31.50 euros to 36.50 euros per share. At the mid-point of the price range, the transaction size would amount to approximately 328.4 million euros. The offering consists of a public offering in Germany as well as private placements in other jurisdictions.

The bookbuilding and offer period will commence after publication of the approved securities prospectus, expected for June 8, 2020, and are expected to end on June 18, 2020. The final offer price and exact number of shares to be placed is expected to be published on June 18, 2020.

The company intends to list its total current share capital of 12 million shares on the regulated market of the Frankfurt Stock Exchange, under the ticker, PSG. The first day of trading is anticipated to be June 19, 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT